vs
Alpha Metallurgical Resources, Inc.（AMR）与登士柏西诺德（XRAY）财务数据对比。点击上方公司名可切换其他公司
登士柏西诺德的季度营收约是Alpha Metallurgical Resources, Inc.的1.9倍（$961.0M vs $519.1M），Alpha Metallurgical Resources, Inc.净利率更高（-3.3% vs -15.2%，领先11.9%），登士柏西诺德同比增速更快（6.2% vs -15.7%），登士柏西诺德自由现金流更多（$60.0M vs $-10.0M），过去两年登士柏西诺德的营收复合增速更高（0.4% vs -22.4%）
阿尔法冶金资源（前身为康图拉能源）是行业领先的煤炭供应商，在阿巴拉契亚北部和中部拥有地下及露天煤矿综合体，在宾夕法尼亚州、弗吉尼亚州和西弗吉尼亚州坐拥大型煤田，生产用于炼钢的冶金煤和用于发电的动力煤，供应全球下游客户。
登士柏西诺德是美国牙科设备及耗材制造商，业务覆盖全球120多个国家，在21个国家设有生产工厂。该公司前身为1993年Gendex公司以5.9亿美元收购登士柏国际后整合组建的企业，是全球牙科领域的重要供应商。
AMR vs XRAY — 直观对比
营收规模更大
XRAY
是对方的1.9倍
$519.1M
营收增速更快
XRAY
高出21.8%
-15.7%
净利率更高
AMR
高出11.9%
-15.2%
自由现金流更多
XRAY
多$70.0M
$-10.0M
两年增速更快
XRAY
近两年复合增速
-22.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $519.1M | $961.0M |
| 净利润 | $-17.3M | $-146.0M |
| 毛利率 | — | 46.1% |
| 营业利润率 | -4.1% | -14.5% |
| 净利率 | -3.3% | -15.2% |
| 营收同比 | -15.7% | 6.2% |
| 净利润同比 | -711.2% | 66.0% |
| 每股收益（稀释后） | $-1.35 | $-0.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRXRAY
| Q4 25 | $519.1M | $961.0M | ||
| Q3 25 | $525.2M | $904.0M | ||
| Q2 25 | $548.7M | $936.0M | ||
| Q1 25 | $529.7M | $879.0M | ||
| Q4 24 | $615.4M | $905.0M | ||
| Q3 24 | $669.8M | $951.0M | ||
| Q2 24 | $800.1M | $984.0M | ||
| Q1 24 | $861.3M | $953.0M |
净利润AMRXRAY
| Q4 25 | $-17.3M | $-146.0M | ||
| Q3 25 | $-5.5M | $-427.0M | ||
| Q2 25 | $-5.0M | $-45.0M | ||
| Q1 25 | $-33.9M | $20.0M | ||
| Q4 24 | $-2.1M | $-430.0M | ||
| Q3 24 | $3.8M | $-494.0M | ||
| Q2 24 | $58.9M | $-4.0M | ||
| Q1 24 | $127.0M | $18.0M |
毛利率AMRXRAY
| Q4 25 | — | 46.1% | ||
| Q3 25 | — | 48.8% | ||
| Q2 25 | — | 52.4% | ||
| Q1 25 | — | 53.0% | ||
| Q4 24 | — | 49.3% | ||
| Q3 24 | — | 52.1% | ||
| Q2 24 | — | 51.9% | ||
| Q1 24 | — | 53.1% |
营业利润率AMRXRAY
| Q4 25 | -4.1% | -14.5% | ||
| Q3 25 | -0.5% | -24.1% | ||
| Q2 25 | 0.5% | -13.7% | ||
| Q1 25 | -7.6% | 7.2% | ||
| Q4 24 | 1.6% | -56.2% | ||
| Q3 24 | 0.8% | -48.6% | ||
| Q2 24 | 8.8% | 5.1% | ||
| Q1 24 | 16.5% | 4.4% |
净利率AMRXRAY
| Q4 25 | -3.3% | -15.2% | ||
| Q3 25 | -1.1% | -47.2% | ||
| Q2 25 | -0.9% | -4.8% | ||
| Q1 25 | -6.4% | 2.3% | ||
| Q4 24 | -0.3% | -47.5% | ||
| Q3 24 | 0.6% | -51.9% | ||
| Q2 24 | 7.4% | -0.4% | ||
| Q1 24 | 14.7% | 1.9% |
每股收益（稀释后）AMRXRAY
| Q4 25 | $-1.35 | $-0.74 | ||
| Q3 25 | $-0.42 | $-2.14 | ||
| Q2 25 | $-0.38 | $-0.22 | ||
| Q1 25 | $-2.60 | $0.10 | ||
| Q4 24 | $-0.09 | $-2.09 | ||
| Q3 24 | $0.29 | $-2.46 | ||
| Q2 24 | $4.49 | $-0.02 | ||
| Q1 24 | $9.59 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $415.6M | $326.0M |
| 总债务越低越好 | $9.8M | $2.3B |
| 股东权益账面价值 | $1.5B | $1.3B |
| 总资产 | $2.3B | $5.4B |
| 负债/权益比越低杠杆越低 | 0.01× | 1.70× |
8季度趋势，按日历期对齐
现金及短期投资AMRXRAY
| Q4 25 | $415.6M | $326.0M | ||
| Q3 25 | $457.9M | $363.0M | ||
| Q2 25 | $449.0M | $359.0M | ||
| Q1 25 | $448.0M | $398.0M | ||
| Q4 24 | $481.6M | $272.0M | ||
| Q3 24 | $484.6M | $296.0M | ||
| Q2 24 | $336.1M | $279.0M | ||
| Q1 24 | $269.4M | $291.0M |
总债务AMRXRAY
| Q4 25 | $9.8M | $2.3B | ||
| Q3 25 | $2.9M | — | ||
| Q2 25 | $3.1M | — | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | $2.9M | $1.7B | ||
| Q3 24 | $3.6M | — | ||
| Q2 24 | $5.3M | — | ||
| Q1 24 | $6.0M | — |
股东权益AMRXRAY
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.6B | $2.0B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.6B | $1.9B | ||
| Q3 24 | $1.7B | $2.5B | ||
| Q2 24 | $1.6B | $3.1B | ||
| Q1 24 | $1.6B | $3.3B |
总资产AMRXRAY
| Q4 25 | $2.3B | $5.4B | ||
| Q3 25 | $2.3B | $5.7B | ||
| Q2 25 | $2.4B | $6.1B | ||
| Q1 25 | $2.4B | $6.0B | ||
| Q4 24 | $2.4B | $5.8B | ||
| Q3 24 | $2.5B | $6.6B | ||
| Q2 24 | $2.5B | $6.9B | ||
| Q1 24 | $2.5B | $7.1B |
负债/权益比AMRXRAY
| Q4 25 | 0.01× | 1.70× | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | 0.90× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.0M | $101.0M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | $60.0M |
| 自由现金流率自由现金流/营收 | -1.9% | 6.2% |
| 资本支出强度资本支出/营收 | 5.6% | 4.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $17.8M | $104.0M |
8季度趋势，按日历期对齐
经营现金流AMRXRAY
| Q4 25 | $19.0M | $101.0M | ||
| Q3 25 | $50.5M | $79.0M | ||
| Q2 25 | $53.2M | $48.0M | ||
| Q1 25 | $22.2M | $7.0M | ||
| Q4 24 | $56.3M | $87.0M | ||
| Q3 24 | $189.5M | $141.0M | ||
| Q2 24 | $138.1M | $208.0M | ||
| Q1 24 | $196.1M | $25.0M |
自由现金流AMRXRAY
| Q4 25 | $-10.0M | $60.0M | ||
| Q3 25 | $25.4M | $40.0M | ||
| Q2 25 | $18.6M | $16.0M | ||
| Q1 25 | $-16.3M | $-12.0M | ||
| Q4 24 | $13.6M | $36.0M | ||
| Q3 24 | $158.0M | $98.0M | ||
| Q2 24 | $77.0M | $156.0M | ||
| Q1 24 | $132.5M | $-9.0M |
自由现金流率AMRXRAY
| Q4 25 | -1.9% | 6.2% | ||
| Q3 25 | 4.8% | 4.4% | ||
| Q2 25 | 3.4% | 1.7% | ||
| Q1 25 | -3.1% | -1.4% | ||
| Q4 24 | 2.2% | 4.0% | ||
| Q3 24 | 23.6% | 10.3% | ||
| Q2 24 | 9.6% | 15.9% | ||
| Q1 24 | 15.4% | -0.9% |
资本支出强度AMRXRAY
| Q4 25 | 5.6% | 4.3% | ||
| Q3 25 | 4.8% | 4.3% | ||
| Q2 25 | 6.3% | 3.4% | ||
| Q1 25 | 7.3% | 2.2% | ||
| Q4 24 | 6.9% | 5.6% | ||
| Q3 24 | 4.7% | 4.5% | ||
| Q2 24 | 7.6% | 5.3% | ||
| Q1 24 | 7.4% | 3.6% |
现金转化率AMRXRAY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | — | ||
| Q3 24 | 49.81× | — | ||
| Q2 24 | 2.34× | — | ||
| Q1 24 | 1.54× | 1.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMR
暂无分部数据
XRAY
| Essential Dental Solutions | $372.0M | 39% |
| Equipment And Instruments | $160.0M | 17% |
| Implants And Prosthetics | $150.0M | 16% |
| CADCAM | $139.0M | 14% |
| Wellspect Healthcare | $88.0M | 9% |
| Orthodontics | $52.0M | 5% |
